• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Immunic Licenses IMU-856 from Daiichi Sankyo americanpharmaceuticalreview
    January 13, 2020
    Immunic announced its subsidiary, Immunic AG, under the terms of its existing option and license agreement with Daiichi Sankyo, has exercised its exclusive global option to license a group of compounds, designated by Immunic as IMU-856.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service